<DOC>
	<DOCNO>NCT00287898</DOCNO>
	<brief_summary>RATIONALE : Genetic counseling may work well telephone in-person . It yet know whether genetic counsel telephone effective standard ( in-person ) genetic counseling woman risk carry BRCA1 BRCA2 mutation . PURPOSE : This randomized phase III trial study telephone-based genetic counseling see well work compare standard ( in-person ) genetic counseling woman risk carry BRCA1 BRCA2 mutation .</brief_summary>
	<brief_title>Telephone-Based Genetic Counseling Standard Genetic Counseling Women Risk Carrying BRCA1 BRCA2 Mutation</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare impact telephone genetic counseling ( TGC ) versus standard genetic counseling ( SGC ) utilization BRCA1/BRCA2 test woman risk carry BRCA1/BRCA2 mutation . - Compare relative efficacy TGC versus SGC satisfaction counsel process , inform decision making , psychosocial distress , quality life . Secondary - Identify participant characteristic predict differential response TGC . - Explore mechanism TGC SGC impact distress quality life . OUTLINE : This randomize , multicenter study . Participants stratify accord participate site . Participants randomize 1 2 group . - Group 1 ( standard genetic counseling ) : Participants undergo in-person genetic counseling session . Participants give option provide blood genetic testing study site . Participants choose undergo genetic test receive result in-person genetic counselor . - Group 2 ( telephone-based genetic counseling ) : Participants undergo telephone-based genetic counseling session . Participants choose undergo genetic test receive pre-labeled blood kit mail . Participants receive result phone genetic counselor . After completion genetic counseling , participant follow periodically 1 year . PROJECTED ACCRUAL : A total 600 participant accrue study .</detailed_description>
	<criteria>DISEASE CHARACTERISTICS : Must least 10 % chance carry BRCA1/BRCA2 gene , define â‰¥ 1 following : Firstdegree relative affect family member 50 % chance inherit BRCA1/BRCA2 mutation Seconddegree relative BRCA1/BRCA2 mutation 25 % risk inheritance ( parent decease ) Obligate gene carrier affect woman Must live within 100 mile Lombardi Comprehensive Cancer Center No 4 week since breast ovarian cancer diagnosis No metastatic inflammatory breast cancer ovarian cancer No stage III breast ovarian cancer undergo concurrent chemotherapy PATIENT CHARACTERISTICS : No psychiatric illness cognitive disorder would preclude informed consent PRIOR CONCURRENT THERAPY : No prior genetic counseling test BRCA1 and/or BRCA2</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>breast cancer</keyword>
</DOC>